Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edelman

Showing results (261-270 of 348) with videos related to

Pageof 35
Sort By:
Cancer Chemotherapy and Pharmacology|January 4, 2001
Phase I study of docetaxel and topotecan in patients with solid tumorsK H Tkaczuk, W C Zamboni, N S Tait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2013
Randomized phase II study of ixabepilone or paclitaxel plus carboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin statusMartin J Edelman, Claus-Peter Schneider, Chun-Ming Tsai, et al.
JCO Precision Oncology|December 14, 2022
Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation TherapyJillian A Moran, Daniel L Adams, Martin J Edelman, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infectionKatherine A Scilla, Dan P Zandberg, Søren M Bentzen, et al.
The Oncologist|May 24, 2017
Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality TherapyKatherine A Scilla, Søren M Bentzen, Vincent K Lam, et al.
JAMA Network Open|August 14, 2023
Development of a Multilevel Model to Identify Patients at Risk for Delay in Starting Cancer TreatmentZachary A K Frosch, Jill Hasler, Elizabeth Handorf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Multicenter trial of EC145 in advanced, folate-receptor positive adenocarcinoma of the lungMartin J Edelman, Wael A Harb, Sridhar E Pal, et al.
Journal of Geriatric Oncology|June 1, 2018
Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622)Josephine L Feliciano, Jennifer G Le-Rademacher, Ajeet Gajra, et al.
ACS Medicinal Chemistry Letters|May 17, 2011
Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring SystemAtul Kondaskar, Shilpi Kondaskar, Raj Kumar, et al.
Nature Communications|June 23, 2015
A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cellsYuping Mei, Yuyan Wang, Priti Kumari, et al.
Pageof 35

Showing results (261-270 of 348) with videos related to

Sort By:
Pageof 35
Cancer Chemotherapy and Pharmacology|January 4, 2001
Phase I study of docetaxel and topotecan in patients with solid tumorsK H Tkaczuk, W C Zamboni, N S Tait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2013
Randomized phase II study of ixabepilone or paclitaxel plus carboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin statusMartin J Edelman, Claus-Peter Schneider, Chun-Ming Tsai, et al.
JCO Precision Oncology|December 14, 2022
Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation TherapyJillian A Moran, Daniel L Adams, Martin J Edelman, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infectionKatherine A Scilla, Dan P Zandberg, Søren M Bentzen, et al.
The Oncologist|May 24, 2017
Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality TherapyKatherine A Scilla, Søren M Bentzen, Vincent K Lam, et al.
JAMA Network Open|August 14, 2023
Development of a Multilevel Model to Identify Patients at Risk for Delay in Starting Cancer TreatmentZachary A K Frosch, Jill Hasler, Elizabeth Handorf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Multicenter trial of EC145 in advanced, folate-receptor positive adenocarcinoma of the lungMartin J Edelman, Wael A Harb, Sridhar E Pal, et al.
Journal of Geriatric Oncology|June 1, 2018
Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622)Josephine L Feliciano, Jennifer G Le-Rademacher, Ajeet Gajra, et al.
ACS Medicinal Chemistry Letters|May 17, 2011
Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring SystemAtul Kondaskar, Shilpi Kondaskar, Raj Kumar, et al.
Nature Communications|June 23, 2015
A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cellsYuping Mei, Yuyan Wang, Priti Kumari, et al.
Pageof 35